Trial Profile
Brain Imaging and Treatment Studies of the Night Eating Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Night eating syndrome
- Focus Therapeutic Use
- 27 Feb 2012 Actual patient number added 87 according to ClinicalTrials.gov.
- 27 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.